Corner Therapeutics
Latest round
- Series A
Last raised
- Apr 2024
Total raised
- $54M
Investors
- 4
About Corner Therapeutics
Based in Massachusetts, US, and founded in 2020 by CEO Steven M. Altschuler, Jonathan Kagan, and Marian R.a. Corner Therapeutics operates as an immunotherapy company that focuses on developing multi-purpose immunotherapies to address a virtually unbounded range of cancers and infectious diseases. The company offers DC Hyperactivation, an immunotherapy platform that enhances dendritic cells' intelligence to generate robust T and B cell-mediated immunity for life. By leveraging hyperactivators, the platform stimulates inflammasome activation within living dendritic cells, leading to long-lasting memory T cell production and effective disease treatment. In addition, Corner Therapeutics utilizes a catalytic adjuvant platform to develop nucleic acid-based vaccines for infection prevention and cancer treatment. Unlike conventional mRNA-LNP vaccines, the platform enhances both cellular and humoral immunity, generating durable memory T cells and preserving antibody responses for lifelong immunity against diseases.
Who invested in Corner Therapeutics
4 investors across 1 round
See all investors in Corner Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Apr 18, 2024
Amount
$54M
Investors
Questions about Corner Therapeutics
Who invested in Corner Therapeutics?
Corner Therapeutics has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Corner Therapeutics raised?
Corner Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Corner Therapeutics last raise money?
Corner Therapeutics's most recent round on record is a Series A, in Apr 2024.
What does Corner Therapeutics do?
Based in Massachusetts, US, and founded in 2020 by CEO Steven M.
Where is Corner Therapeutics headquartered?
Corner Therapeutics is headquartered in Watertown, US.
Which VCs invest in companies like Corner Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Corner Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Corner Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.